Galmed Pharmaceuticals
GLMD
#11043
Rank
S$6.37 M
Marketcap
S$5.97
Share price
21.05%
Change (1 day)
386.19%
Change (1 year)

Earnings for Galmed Pharmaceuticals (GLMD)

Earnings in 2026 (TTM): -S$14.61 Million

According to Galmed Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -S$13.29 Million a decrease over its 2024 earnings that were of -S$9.7 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galmed Pharmaceuticals from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$14.61 Million9.89%
2025 -S$13.29 Million37.14%
2024 -S$9.7 Million8.75%
2023 -S$8.92 Million-61.31%
2022 -S$23.04 Million-44.97%
2021 -S$41.86 Million12.85%
2020 -S$37.09 Million40.61%
2019 -S$26.38 Million109.19%
2018 -S$12.61 Million-20.47%
2017 -S$15.86 Million-27%
2016 -S$21.72 Million58.6%
2015 -S$13.7 Million16.7%
2014 -S$11.74 Million-47.94%
2013 -S$22.54 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Evoke Pharma
EVOK
-S$6.1 Million-58.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
-S$3.09 Billion 20,987.19%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Aerie Pharmaceuticals
AERI
-S$29.96 Million 104.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalent
CTLT
-S$0.12 Billion 702.26%๐Ÿ‡บ๐Ÿ‡ธ USA